Summary: PathAI partners with Labcorp for nationwide rollout

Why It Matters: PathAI is moving from clinical trials into large-scale clinical use. By partnering with a major lab like Labcorp, they can reach many more doctors and patients across the country.

What Changed:

• Replaced the homepage announcement about FDA qualification for MASH trials with a new headline about the Labcorp partnership.
• Added a new press release regarding the nationwide deployment of the AISight Dx platform.
• Updated the footer tracking code to MKT-012-15.